On Monday, Geron Corp (NASDAQ: GERN) was -5.96%% drop from the session before settling in for the closing price of $1.51. A 52-week range for GERN has been $1.17 – $5.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.60%. When this article was written, the company’s average yearly earnings per share was at 52.66%. With a float of $603.40 million, this company’s outstanding shares have now reached $636.92 million.
Let’s determine the extent of company efficiency that accounts for 229 employees. In terms of profitability, gross margin is 97.85%, operating margin of -115.49%, and the pretax margin is -119.54%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Geron Corp stocks. The insider ownership of Geron Corp is 5.26%, while institutional ownership is 75.72%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 52.66% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
You can see what Geron Corp (GERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 8.54 million, which is a drop from its year-to-date volume of 13.4 million. As of the previous 9 days, the stock’s Stochastic %D was 44.03%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 13.02%, which indicates a significant increase from 7.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.63% in the past 14 days, which was lower than the 92.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4078, while its 200-day Moving Average is $2.8344. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.4733. Second resistance stands at $1.5267. The third major resistance level sits at $1.5533. If the price goes on to break the first support level at $1.3933, it is likely to go to the next support level at $1.3667. Now, if the price goes above the second support level, the third support stands at $1.3133.
Geron Corp (NASDAQ: GERN) Key Stats
There are 636,918K outstanding shares of the company, which has a market capitalization of 904.43 million. As of now, sales total 76,990 K while income totals -174,570 K. Its latest quarter income was 39,600 K while its last quarter net income were -19,840 K.
